Mabwell (Shanghai) Bioscience Co., Ltd.
Status: Publicly traded
Direct answer
Mabwell (Shanghai) Bioscience Co., Ltd. is publicly traded on SHH under the ticker 688062.SS.
Founded in 2017 and based in Shanghai, China, Mabwell (Shanghai) Bioscience Co., Ltd. is a biopharmaceutical enterprise dedicated to the discovery, development, production, and global commercialization of biological products. The company's comprehensive portfolio addresses a wide spectrum of medical conditions, including autoimmune disorders, various cancers, eye diseases, infectious ailments, and metabolic...
Can you invest in Mabwell (Shanghai) Bioscience Co., Ltd.?
Yes. Mabwell (Shanghai) Bioscience Co., Ltd. trades publicly on SHH as 688062.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Mabwell (Shanghai) Bioscience Co., Ltd.
Detailed equity research is provided by MarketSnap.